KE

Katie Ellias

Venture Capital, Biotechnology, Medical Devices, Board of Directors, Venture Philanthropy

Greater Boston

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

Interpersonal Skills
Board Level
Business Development
Product Launch
Marketing
Negotiation
Interventional Cardiology
Cardiac Surgery
Medical Devices
Commercialization
Cross-functional Team Leadership
Product Marketing
Product Management
Lifesciences
Start-ups
Sales Effectiveness
Product Development
Mergers & Acquisitions
Vascular
Strategy

Education

Work Experience

  • Managing Director

    2018

    The Fund is a venture philanthropy fund committed to accelerating life-changing solutions to treat, prevent, and cure type 1 diabetes (T1D) through catalytic equity investments. While independently managed, the Fund is affiliated with JDRF, the leading global organization funding T1D research. Through its investments in partnership with private capital, including venture capital, corporations and foundations, the T1D Fund seeks to attract the private investment necessary to advance cures and therapies into the hands of those living with T1D. The T1D Fund invests in areas strategically aligned with JDRF, with an exclusive focus on supporting the best commercial opportunities. The T1D Fund reinvests any realized gains into new investments to further its mission.

  • Board Member

    2023

2020

  • Board Member

    2020

2021

  • Board Observer

    2021

  • Board Observer

    2020

  • Board Member

    2019

2019

  • Board Observer

    2019

  • Board Observer

    2018

  • Board Member

    2019 - 2022